Skip to the page

Data / Drug companies / Kareway Product, Inc.

Kareway Product, Inc.: 7 products in the FDA NDC directory, labeler code 67510

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Kareway Product, Inc. (labeler code 67510) lists 7 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 7 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 3, 2026.

The request: Watch Kareway Product, Inc. (FDA labeler code 67510): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
67510
Products in commercial distribution
7
Packages
9
Finished drugs by generic name
6
Prescription products
0
Over the counter products
7
Flagged as original packager
6 of 6 products that carry the flag
Started marketing in the last 12 months
1
Earliest marketing start
January 23, 2012
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs685.7%
Generic drugs (ANDA)114.3%

Products by type

TypeProductsShare
Over the counter drugs7100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Lidocaine, menthol234
Capsaicin166
Dl-camphor, l-menthol, methyl salicylate patch11
Ibuprofen1190
Lidocaine hcl and menthol13
Camphor, menthol, methyl salicylate136

Dosage forms

Dosage formProductsShare
Patch571.4%
Tablet, coated114.3%
Cream114.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ibuprofen67510-0173Tablet, coatedGeneric drugs (ANDA)August 3, 2026
Lidocaine with Menthol67510-0681CreamOver the counter monograph drugsApril 8, 2025
Pure-Aid67510-0289PatchOver the counter monograph drugsJune 5, 2018
Soundbody67510-0636PatchOver the counter monograph drugsMarch 2, 2018
Pure-Aid67510-0284PatchOver the counter monograph drugsMarch 2, 2018
Pain Relief67510-0305PatchOver the counter monograph drugsJanuary 25, 2012
Capsaicin Pain Relief67510-0303PatchOver the counter monograph drugsJanuary 23, 2012

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.